DOJ Probing Par Over Megace Off-Label Marketing

Law360, New York (March 30, 2009, 12:00 AM EDT) -- The U.S. Department of Justice has launched an investigation into Par Pharmaceutical Cos. Inc.'s promotional practices for its appetite enhancer Megace ES, the drugmaker said in a regulatory filing.

In a filing with the U.S. Securities and Exchange Commission on Friday, Par Pharmaceutical said the DOJ was investigating promotional practices in the sales and marketing of Megace ES, which is produced by Strativa Pharmaceuticals, a wholly owned and operated subsidiary of Par Pharmaceutical.

“We were served with a subpoena by the Department of Justice for documents...
To view the full article, register now.